(1->4)-beta-D-glucan multiple interactions ISO RGD:1314414 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MFAP2 mRNA CTD PMID:36331819 1,2-dimethylhydrazine increases expression ISO RGD:1314414 6480464 1, 2-Dimethylhydrazine results in increased expression of MFAP2 mRNA CTD PMID:22206623 17alpha-ethynylestradiol affects expression ISO RGD:1314414 6480464 Ethinyl Estradiol affects the expression of MFAP2 mRNA CTD PMID:17555576 17alpha-ethynylestradiol multiple interactions ISO RGD:1314414 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MFAP2 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:1314413 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of MFAP2 mRNA, [Progesterone co-treated with Estradiol] results in decreased expression of MFAP2 mRNA CTD PMID:17404688 , PMID:30165855 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MFAP2 mRNA CTD PMID:32741896 17beta-estradiol multiple interactions ISO RGD:1314414 6480464 [bisphenol A results in increased susceptibility to Estradiol] which results in decreased expression of MFAP2 mRNA CTD PMID:27312807 17beta-estradiol increases expression ISO RGD:1314414 6480464 Estradiol results in increased expression of MFAP2 mRNA CTD PMID:19484750 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MFAP2 mRNA CTD PMID:32741896 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO RGD:1314414 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1314414 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MFAP2 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of MFAP2 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1314414 6480464 Tetrachlorodibenzodioxin results in decreased expression of MFAP2 mRNA CTD PMID:19465110 2,3,7,8-Tetrachlorodibenzofuran increases expression EXP 6480464 2 more ... CTD PMID:32109520 4,4'-sulfonyldiphenol increases expression ISO RGD:1314414 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of MFAP2 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide increases expression ISO RGD:1314414 6480464 Fenretinide results in increased expression of MFAP2 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine affects expression ISO RGD:1314413 6480464 Decitabine affects the expression of MFAP2 mRNA CTD PMID:17145863 5-azacytidine decreases expression ISO RGD:1314413 6480464 Azacitidine results in decreased expression of MFAP2 mRNA CTD PMID:20823114 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of MFAP2 mRNA CTD PMID:24780913 9-cis-retinoic acid decreases expression ISO RGD:1314413 6480464 Alitretinoin results in decreased expression of MFAP2 mRNA CTD PMID:15982314 aconitine increases expression EXP 6480464 Aconitine results in increased expression of MFAP2 protein CTD PMID:33236894 acrylamide affects expression EXP 6480464 Acrylamide affects the expression of MFAP2 mRNA CTD PMID:28959563 acrylamide decreases expression ISO RGD:1314413 6480464 Acrylamide results in decreased expression of MFAP2 mRNA CTD PMID:32763439 all-trans-4-oxoretinoic acid decreases expression ISO RGD:1314413 6480464 4-oxoretinoic acid results in decreased expression of MFAP2 mRNA CTD PMID:15982314 all-trans-retinoic acid decreases expression ISO RGD:1314413 6480464 Tretinoin metabolite results in decreased expression of MFAP2 mRNA, Tretinoin results in decreased expression of MFAP2 mRNA CTD PMID:15982314 antirheumatic drug increases expression ISO RGD:1314413 6480464 Antirheumatic Agents results in increased expression of MFAP2 mRNA CTD PMID:24449571 arsane decreases methylation ISO RGD:1314413 6480464 Arsenic results in decreased methylation of MFAP2 5' UTR CTD PMID:31135185 arsenic atom decreases methylation ISO RGD:1314413 6480464 Arsenic results in decreased methylation of MFAP2 5' UTR CTD PMID:31135185 arsenite(3-) decreases expression ISO RGD:1314413 6480464 arsenite results in decreased expression of MFAP2 mRNA CTD PMID:23974009 arsenite(3-) increases methylation ISO RGD:1314413 6480464 arsenite results in increased methylation of MFAP2 promoter CTD PMID:23974009 benzo[a]pyrene decreases expression ISO RGD:1314414 6480464 Benzo(a)pyrene results in decreased expression of MFAP2 mRNA CTD PMID:21569818 more ... benzo[a]pyrene affects methylation ISO RGD:1314413 6480464 Benzo(a)pyrene affects the methylation of MFAP2 promoter CTD PMID:27901495 benzo[a]pyrene increases methylation ISO RGD:1314413 6480464 Benzo(a)pyrene results in increased methylation of MFAP2 5' UTR CTD PMID:27901495 benzo[a]pyrene multiple interactions ISO RGD:1314414 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MFAP2 mRNA CTD PMID:27858113 benzo[b]fluoranthene decreases expression ISO RGD:1314414 6480464 benzo(b)fluoranthene results in decreased expression of MFAP2 mRNA CTD PMID:26377693 benzo[b]fluoranthene multiple interactions ISO RGD:1314414 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MFAP2 mRNA CTD PMID:27858113 benzo[e]pyrene increases methylation ISO RGD:1314413 6480464 benzo(e)pyrene results in increased methylation of MFAP2 intron CTD PMID:30157460 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of MFAP2 mRNA CTD PMID:25181051 , PMID:34947998 bisphenol A decreases methylation ISO RGD:1314413 6480464 bisphenol A results in decreased methylation of MFAP2 gene CTD PMID:31601247 bisphenol A multiple interactions ISO RGD:1314414 6480464 [bisphenol A results in increased susceptibility to Estradiol] which results in decreased expression of MFAP2 mRNA CTD PMID:27312807 bisphenol A decreases methylation ISO RGD:1314414 6480464 bisphenol A results in decreased methylation of MFAP2 promoter CTD PMID:27312807 bisphenol A increases expression ISO RGD:1314414 6480464 bisphenol A results in increased expression of MFAP2 mRNA CTD PMID:30951980 bisphenol A increases expression ISO RGD:1314413 6480464 bisphenol A results in increased expression of MFAP2 mRNA CTD PMID:27685785 Bisphenol B increases expression ISO RGD:1314413 6480464 bisphenol B results in increased expression of MFAP2 protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:1314414 6480464 bisphenol F results in increased expression of MFAP2 mRNA CTD PMID:30951980 bisphenol F increases expression ISO RGD:1314413 6480464 bisphenol F results in increased expression of MFAP2 protein CTD PMID:34186270 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of MFAP2 mRNA CTD PMID:19167457 calcitriol decreases expression ISO RGD:1314413 6480464 Calcitriol results in decreased expression of MFAP2 mRNA CTD PMID:26485663 choline multiple interactions ISO RGD:1314414 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MFAP2 mRNA CTD PMID:20938992 chrysene multiple interactions ISO RGD:1314414 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MFAP2 mRNA CTD PMID:27858113 ciguatoxin CTX1B affects expression ISO RGD:1314414 6480464 Ciguatoxins affects the expression of MFAP2 mRNA CTD PMID:18353800 copper atom multiple interactions ISO RGD:1314413 6480464 [NSC 689534 binds to Copper] which results in increased expression of MFAP2 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:1314413 6480464 [NSC 689534 binds to Copper] which results in increased expression of MFAP2 mRNA CTD PMID:20971185 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of MFAP2 mRNA CTD PMID:26577399 dexamethasone decreases expression ISO RGD:1314413 6480464 Dexamethasone results in decreased expression of MFAP2 mRNA CTD PMID:25047013 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of MFAP2 mRNA CTD PMID:21266533 dimethylarsinic acid decreases expression ISO RGD:1314414 6480464 Cacodylic Acid results in decreased expression of MFAP2 mRNA CTD PMID:32052077 diuron decreases expression EXP 6480464 Diuron results in decreased expression of MFAP2 mRNA CTD PMID:25152437 doxorubicin decreases expression ISO RGD:1314413 6480464 Doxorubicin results in decreased expression of MFAP2 mRNA CTD PMID:29803840 elemental selenium increases expression ISO RGD:1314413 6480464 Selenium results in increased expression of MFAP2 mRNA CTD PMID:19244175 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of MFAP2 mRNA CTD PMID:29391264 folic acid multiple interactions ISO RGD:1314414 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MFAP2 mRNA CTD PMID:20938992 furan increases expression EXP 6480464 furan results in increased expression of MFAP2 mRNA CTD PMID:27387713 hexane decreases methylation EXP 6480464 n-hexane results in decreased methylation of MFAP2 promoter CTD PMID:23740543 Indeno[1,2,3-cd]pyrene decreases expression ISO RGD:1314414 6480464 indeno(1 more ... CTD PMID:26377693 isotretinoin decreases expression ISO RGD:1314413 6480464 Isotretinoin results in decreased expression of MFAP2 mRNA CTD PMID:15982314 isotretinoin increases expression ISO RGD:1314413 6480464 Isotretinoin results in increased expression of MFAP2 mRNA CTD PMID:20436886 L-methionine multiple interactions ISO RGD:1314414 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MFAP2 mRNA CTD PMID:20938992 manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of MFAP2 mRNA CTD PMID:28801915 manganese(II) chloride decreases methylation EXP 6480464 manganese chloride results in decreased methylation of MFAP2 gene CTD PMID:28801915 methapyrilene increases methylation ISO RGD:1314413 6480464 Methapyrilene results in increased methylation of MFAP2 intron CTD PMID:30157460 N-methyl-4-phenylpyridinium increases expression ISO RGD:1314413 6480464 1-Methyl-4-phenylpyridinium results in increased expression of MFAP2 mRNA CTD PMID:24810058 N-methyl-4-phenylpyridinium decreases methylation EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased methylation of MFAP2 gene CTD PMID:28801915 ozone multiple interactions ISO RGD:1314414 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of MFAP2 mRNA CTD PMID:34911549 paracetamol increases expression ISO RGD:1314413 6480464 Acetaminophen results in increased expression of MFAP2 mRNA CTD PMID:22230336 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1314414 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MFAP2 mRNA CTD PMID:36331819 progesterone multiple interactions ISO RGD:1314413 6480464 [Progesterone co-treated with Estradiol] results in decreased expression of MFAP2 mRNA CTD PMID:17404688 resveratrol multiple interactions ISO RGD:1314413 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of MFAP2 mRNA CTD PMID:23557933 selenium atom increases expression ISO RGD:1314413 6480464 Selenium results in increased expression of MFAP2 mRNA CTD PMID:19244175 silicon dioxide decreases expression ISO RGD:1314413 6480464 Silicon Dioxide analog results in decreased expression of MFAP2 mRNA CTD PMID:25895662 sulforaphane decreases expression ISO RGD:1314413 6480464 sulforaphane results in decreased expression of MFAP2 mRNA CTD PMID:31838189 sunitinib increases expression ISO RGD:1314413 6480464 Sunitinib results in increased expression of MFAP2 mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:1314414 6480464 Tamoxifen affects the expression of MFAP2 mRNA CTD PMID:17555576 temozolomide decreases expression ISO RGD:1314413 6480464 Temozolomide results in decreased expression of MFAP2 mRNA CTD PMID:31758290 testosterone increases expression ISO RGD:1314413 6480464 Testosterone results in increased expression of MFAP2 mRNA CTD PMID:33359661 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MFAP2 mRNA CTD PMID:32741896 tetraphene multiple interactions ISO RGD:1314414 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MFAP2 mRNA CTD PMID:27858113 titanium dioxide decreases expression ISO RGD:1314414 6480464 titanium dioxide results in decreased expression of MFAP2 mRNA CTD PMID:23557971 titanium dioxide multiple interactions ISO RGD:1314413 6480464 [Vitallium analog binds to titanium dioxide] which results in increased expression of MFAP2 mRNA CTD PMID:23825117 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of MFAP2 mRNA CTD PMID:33387578 valproic acid affects expression ISO RGD:1314413 6480464 Valproic Acid affects the expression of MFAP2 mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:1314413 6480464 Valproic Acid results in increased expression of MFAP2 mRNA CTD PMID:23179753 , PMID:27188386 valproic acid increases methylation ISO RGD:1314413 6480464 Valproic Acid results in increased methylation of MFAP2 gene CTD PMID:29154799 vanadium atom increases expression ISO RGD:1314413 6480464 Vanadium results in increased expression of MFAP2 mRNA CTD PMID:19000753 vanadium(0) increases expression ISO RGD:1314413 6480464 Vanadium results in increased expression of MFAP2 mRNA CTD PMID:19000753 vitamin E increases expression ISO RGD:1314413 6480464 Vitamin E results in increased expression of MFAP2 mRNA CTD PMID:19244175